The 340B program spent $43.9 billion in 2021, supporting nearly 50,000 hospitals with discounted outpatient drugs. Cancer drugs constitute 41% of 340B purchases, with outpatient departments and ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

Weaknesses in the oversight of the 340 drug-pricing program may allow some hospitals to get discounts they are ineligible for, a newly released report from the Government Accountability Office found.

On July 31, 2025, the Health Resources and Services Administration (HRSA) released long-awaited guidance establishing a 340B Rebate Model Pilot Program (Pilot Program). The announcement marks a ...

When the 340B drug pricing program was established in 1992, Congress intended for the program to help low-income and uninsured patients with their prescription drugs. The pharmaceutical companies ...

University of Minnesota researchers detail the loopholes and pitfalls of drug companies’ discounted pricing program and what Minnesota entities are doing to enhance transparency. The 340B Drug Pricing ...

On February 2, 2024, the “gang of six”—a bipartisan group of six senators who have traditionally championed reforms to the 340B program 1 —introduced a discussion draft of a bill that would modify the ...

State lawmakers are pushing a measure to expand a controversial federal program that gives hospitals hefty discounts on drugs as the Trump administration seeks to curtail spending within the program.

The exterior of the U.S. Capitol on Jan. 3, 2024. The trucking industry inched toward a longtime goal with the passage of a tax bill by the House of Representatives on Wednesday. This story was ...